CPHN.SW

Basic Materials Paper & Paper Products

CPH Group AG

CHF 56.80

-0.80 -1.39% today

Price History

Not enough data

Key Stats

Market Cap

340.52M

Avg Volume

1,962

P/E (TTM)

16.56

EPS

CHF 3.43

52W High

CHF 72.60

52W Low

CHF 54.20

Div. Yield

3.5%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

11.59

P/B Ratio

1.62

P/S Ratio

1.02

EV/EBITDA

7.75

EV/Revenue

1.10

Margins

Gross Margin 48.4%

Operating Margin 10.8%

Net Margin 6.1%

EBITDA Margin 14.2%

Growth & Returns

Revenue Growth (YoY)

0.1%

Earnings Growth (YoY)

(16.5%)

Earnings Growth (QoQ)

(16.8%)

Return on Equity

10.1%

Return on Assets

4.9%

Liquidity & Leverage

Current Ratio

1.49

Quick Ratio

0.79

Debt / Equity

0.28

Total Cash

32.96M

Total Debt

58.40M

About

CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland, Bosnia and Herzegovina, the USA, Canada, China, and India. The Perlen Packaging segment focuses on the pharmaceutical industry, supplying coated plastic films used primarily in blister packaging to protect medications, as well as vials and containers for medical use; and PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry. CPH Group AG was founded in 1818 and is based in Perlen, Switzerland.

cph.ch